Keyword Index
Browse for an article via relevant keywords across our entire electronic archive
Search results for: R
Results 1 - 10 of 364 shown below
R115777 (tipifarnib)
A Sparreboom, D F S Kehrer, R H J Mathijssen, R Xie, M J A de Jonge, P de Bruijn, A S T Planting, F A L M Eskens, C Verheij, G de Heus, A Klaren, S Zhang, T Verhaeghe, P A Palmer and J Verweij
Phase I and pharmacokinetic study of irinotecan in combination with R115777, a farnesyl protein transferase inhibitor
advance online publication, 2004-03-23 00:00:00.000;
doi:10.1038/sj.bjc.6601732
Abstract | Full article | PDF
R116010
J Van heusden, R Van Ginckel, H Bruwiere, P Moelans, B Janssen, W Floren, B J van der Leede, J van Dun, G Sanz, M Venet, L Dillen, C Van Hove, G Willemsens, M Janicot and W Wouters
Inhibition of all-TRANS-retinoic acid metabolism by R116010 induces antitumour activity
doi:10.1038/sj.bjc.6600056
Abstract | Full article | PDF
-
J L Armstrong, M Ruiz, A V Boddy, C P F Redfern, A D J Pearson and G J Veal
Increasing the intracellular availability of all-trans retinoic acid in neuroblastoma cells
advance online publication, 2005-02-15 00:00:00.000;
doi:10.1038/sj.bjc.6602398
Abstract | Full article | PDF
-
J L Armstrong, G A Taylor, H D Thomas, A V Boddy, C P F Redfern and G J Veal
Molecular targeting of retinoic acid metabolism in neuroblastoma: the role of the CYP26 inhibitor R116010 in vitro and in vivo
advance online publication, 2007-05-08 00:00:00.000;
doi:10.1038/sj.bjc.6603779
Abstract | Full article | PDF
RA
J Van heusden, R Van Ginckel, H Bruwiere, P Moelans, B Janssen, W Floren, B J van der Leede, J van Dun, G Sanz, M Venet, L Dillen, C Van Hove, G Willemsens, M Janicot and W Wouters
Inhibition of all-TRANS-retinoic acid metabolism by R116010 induces antitumour activity
doi:10.1038/sj.bjc.6600056
Abstract | Full article | PDF
Rab1a gene
K Shimada, K Uzawa, M Kato, Y Endo, M Shiiba, H Bukawa, H Yokoe, N Seki and H Tanzawa
Aberrant expression of RAB1A in human tongue cancer
advance online publication, 2005-05-03 00:00:00.000;
doi:10.1038/sj.bjc.6602594
Abstract | Full article | PDF
RAC 3
V J Gnanapragasam, H Y Leung, A S Pulimood, D E Neal and C N Robson
Expression of RAC 3, a steroid hormone receptor co-activator in prostate cancer
doi:10.1054/bjoc.2001.2179
race
A S Adelman, C C McLaughlin, X-C Wu, V W Chen and F D Groves
Urbanisation and incidence of acute lymphocytic leukaemia among United States children aged 0–4
advance online publication, 2005-05-10 00:00:00.000;
doi:10.1038/sj.bjc.6602607
Abstract | Full article | PDF
-
A S Adelman, F D Groves, K O'Rourke, D Sinha, T C Hulsey, A B Lawson, D Wartenberg and D G Hoel
Residential mobility and risk of childhood acute lymphoblastic leukaemia: an ecological study
advance online publication, 2007-05-29 00:00:00.000;
doi:10.1038/sj.bjc.6603793
Abstract | Full article | PDF
-
J L Ryan, C Bole, J T Hickok, C Figueroa-Moseley, L Colman, R C Khanna, A P Pentland and G R Morrow
Post-treatment skin reactions reported by cancer patients differ by race, not by treatment or expectations
advance online publication, 2007-06-12 00:00:00.000;
doi:10.1038/sj.bjc.6603842
Abstract | Full article | PDF
racial aspects
R B Hayes, L M Pottern, H Strickler, C Rabkin, V Pope, G M Swanson, R S Greenberg, J B Schoenberg, J Liff, A G Schwartz, R N Hoover and J F Fraumeni
Sexual behaviour, STDs and risks for prostate cancer
doi:10.1054/bjoc.1999.0986
Rad50
E Vilar, M Scaltriti, J Balmaña, C Saura, M Guzman, J Arribas, J Baselga and J Tabernero
Microsatellite instability due to hMLH1 deficiency is associated with increased cytotoxicity to irinotecan in human colorectal cancer cell lines
advance online publication, 2008-10-21 00:00:00.000;
doi:10.1038/sj.bjc.6604691
Abstract | Full article | PDF
RAD51
A Sak, G Stueben, M Groneberg, W Böcker and M Stuschke
Targeting of Rad51-dependent homologous recombination: implications for the radiation sensitivity of human lung cancer cell lines
advance online publication, 2005-03-22 00:00:00.000;
doi:10.1038/sj.bjc.6602457
Abstract | Full article | PDF
-
G-B Qiao, Y-L Wu, X-N Yang, W-Z Zhong, D Xie, X-Y Guan, D Fischer, H-C Kolberg, S Kruger and H-W Stuerzbecher
High-level expression of Rad51 is an independent prognostic marker of survival in non-small-cell lung cancer patients
advance online publication, 2005-06-14 00:00:00.000;
doi:10.1038/sj.bjc.6602665
Abstract | Full article | PDF
-
R Gonzalez, J M Silva, G Dominguez, J M Garcia, G Martinez, J Vargas, M Provencio, P España and F Bonilla
Detection of loss of heterozygosity at RAD51, RAD52, RAD54 and BRCA1 and BRCA2 loci in breast cancer: pathological correlations
doi:10.1038/sj.bjc.6690722
RAD51 gene
L Kadouri, Z Kote-Jarai, A Hubert, F Durocher, D Abeliovich, B Glaser, T Hamburger, R A Eeles and T Peretz
A single-nucleotide polymorphism in the RAD51 gene modifies breast cancer risk in BRCA2 carriers, but not in BRCA1 carriers or noncarriers
advance online publication, 2004-04-27 00:00:00.000;
doi:10.1038/sj.bjc.6601837
Abstract | Full article | PDF
